Spots Global Cancer Trial Database for acromegaly
Every month we try and update this database with for acromegaly cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | NCT01794793 | Cushing's Disea... Acromegaly Neuroendocrine ... Pituitary Tumor... Ectopic ACTH Se... Dumping Syndrom... Prostate Cancer Melanoma Negati... Melanoma Negati... | Pasireotide Cabergoline Pasireotide | 18 Years - | RECORDATI GROUP | |
| Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors | NCT01568359 | Acromegaly Nonfunctioning ... | 18 Years - | Emory University | ||
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | NCT02060383 | Cushing's Disea... Acromegaly | Pasireotide s.c... Sitagliptin Liraglutide Insulin Pasireotide LAR Metformin | 18 Years - | Novartis | |
| Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models | NCT06326853 | Endocrine Disor... Adiposity Pituitary Adeno... Cushing Syndrom... Acromegaly Hypopituitarism | 18 Years - | IRCCS San Raffaele | ||
| Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly | NCT00461149 | Acromegaly | Octreotide-LAR | 18 Years - | Federico II University | |
| PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon | NCT02854228 | Pituitary Tumor | - | Hospices Civils de Lyon | ||
| A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) | NCT05364944 | Acromegaly GEP-NET | Debio 4126 Sandostatin LAR Somatuline ATG | 18 Years - | Debiopharm International SA | |
| Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly | NCT00461149 | Acromegaly | Octreotide-LAR | 18 Years - | Federico II University | |
| Somatuline Predictive Factors in Acromegaly and NET | NCT01840449 | Acromegaly Neuroendocrine ... | Somatuline Auto... | 18 Years - | Ipsen | |
| A Pilot Study of Pre- and Post-operative Use of Somatuline Depot. | NCT01861717 | Acromegaly | lanreotide | 18 Years - 75 Years | Saint John's Cancer Institute | |
| Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly | NCT00627796 | Acromegaly | Lanreotide-Auto... | 18 Years - 80 Years | Federico II University | |
| Seoul National University Pituitary Disease Cohort Study | NCT03474601 | Pituitary Disea... Pituitary Incid... Acromegaly Central Diabete... Pituitary Stalk... Cushing's Disea... Pituitary Tumor Prolactinoma | Dynamic hormone... | 18 Years - | Seoul National University Hospital | |
| The TMS Treatment for Postoperative Headache in GH Tumor | NCT04529356 | Headache Pituitary Tumor Acromegaly | Transcranial ma... Acetaminophen | 18 Years - 60 Years | Huashan Hospital | |
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | NCT02060383 | Cushing's Disea... Acromegaly | Pasireotide s.c... Sitagliptin Liraglutide Insulin Pasireotide LAR Metformin | 18 Years - | Novartis | |
| Somatuline Predictive Factors in Acromegaly and NET | NCT01840449 | Acromegaly Neuroendocrine ... | Somatuline Auto... | 18 Years - | Ipsen | |
| The Treatment and Natural History of Acromegaly | NCT00001981 | Acromegaly Pituitary Neopl... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly | NCT01137682 | Acromegaly | Pasireotide octreotide LAR ... lanreotide ATG ... | 18 Years - | Novartis | |
| Sandostatin LAR Depot vs. Surgery for Treating Acromegaly | NCT00001860 | Acromegaly Pituitary Neopl... | Sandostatin LAR... | - | National Institutes of Health Clinical Center (CC) | |
| Prediction of Tumor Shrinkage in Acromegaly | NCT00616408 | Acromegaly | Octreotide-LAR | 18 Years - 85 Years | Federico II University | |
| A Prospective Study of Outcome After Therapy for Acromegaly | NCT01809808 | Acromegaly | Surgery for acr... Medications for... Total body magn... Adipose Tissue ... | 18 Years - | Columbia University | |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | NCT01794793 | Cushing's Disea... Acromegaly Neuroendocrine ... Pituitary Tumor... Ectopic ACTH Se... Dumping Syndrom... Prostate Cancer Melanoma Negati... Melanoma Negati... | Pasireotide Cabergoline Pasireotide | 18 Years - | RECORDATI GROUP | |
| Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery | NCT05149495 | Acromegaly | 18 Years - | University Hospital, Strasbourg, France | ||
| Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly | NCT00627796 | Acromegaly | Lanreotide-Auto... | 18 Years - 80 Years | Federico II University | |
| Long Term Outcome Study in Patients With Pituitary Disorders | NCT03665064 | Pituitary Disea... Pituitary Neopl... | - | University of Alberta | ||
| Seoul National University Pituitary Disease Cohort Study | NCT03474601 | Pituitary Disea... Pituitary Incid... Acromegaly Central Diabete... Pituitary Stalk... Cushing's Disea... Pituitary Tumor Prolactinoma | Dynamic hormone... | 18 Years - | Seoul National University Hospital | |
| Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA | NCT00461188 | Acromegaly Gigantism Familial Isolat... FIPA Pituitary Adeno... PAP | 6 Years - | Barts & The London NHS Trust | ||
| Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma | NCT00598949 | Pituitary Tumor | 18 Years - | Cedars-Sinai Medical Center | ||
| Ga-68-DOTATOC -PET in the Management of Pituitary Tumours | NCT02419664 | Pituitary Tumou... | Gallium-68 DOTA... | 18 Years - | Göteborg University | |
| Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma | NCT03439709 | Acromegaly Due ... | Gamma knife rad... Lanreotide 60Mg... | 18 Years - 70 Years | Samsung Medical Center | |
| Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery | NCT05149495 | Acromegaly | 18 Years - | University Hospital, Strasbourg, France | ||
| A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly | NCT06253897 | Gastro-enteropa... Acromegaly | 18 Years - | Ipsen | ||
| A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) | NCT05364944 | Acromegaly GEP-NET | Debio 4126 Sandostatin LAR Somatuline ATG | 18 Years - | Debiopharm International SA | |
| PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon | NCT02854228 | Pituitary Tumor | - | Hospices Civils de Lyon | ||
| Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) | NCT02299089 | Acromegaly Neuroendocrine ... | octreotide Flui... | 18 Years - | Camurus AB | |
| The Treatment and Natural History of Acromegaly | NCT00001981 | Acromegaly Pituitary Neopl... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Seoul National University Pituitary Disease Cohort Study | NCT03474601 | Pituitary Disea... Pituitary Incid... Acromegaly Central Diabete... Pituitary Stalk... Cushing's Disea... Pituitary Tumor Prolactinoma | Dynamic hormone... | 18 Years - | Seoul National University Hospital | |
| Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma | NCT00598949 | Pituitary Tumor | 18 Years - | Cedars-Sinai Medical Center | ||
| Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) | NCT02299089 | Acromegaly Neuroendocrine ... | octreotide Flui... | 18 Years - | Camurus AB | |
| Long Term Outcome Study in Patients With Pituitary Disorders | NCT03665064 | Pituitary Disea... Pituitary Neopl... | - | University of Alberta |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
